Quantcast
Channel: Endpoints News
Viewing all articles
Browse latest Browse all 2658

Catalent to make CAR-T for Galapagos; Kindeva gets $129M for nerve agent antidote

$
0
0
Welcome to Endpoints News’ manufacturing briefs, where we bring you essential news on new builds, collaborations, recalls and more. Catalent said it will manufacture Galapagos’ clinical-stage CAR T therapy, dubbed GLPG5101 ...

Viewing all articles
Browse latest Browse all 2658

Trending Articles